Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

P4HB Maintains Wnt-Dependent Stemness in Glioblastoma Stem Cell as a Precision Therapeutic and Diagnostic Marker

ABSTRACT: P4HB Maintains Wnt-Dependent Stemness in Glioblastoma Stem Cell as a Precision Therapeutic and Diagnostic Marker

PROVIDER: PRJNA1132963 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

P4HB Maintains Wnt-Dependent Stemness in Glioblastoma Stem Cell as a Precision Therapeutic and Diagnostic Marker

Project description:Glioblastoma stem cells (GSCs) are pivotal in the recurrence and drug resistance of Glioblastoma multiforme (GBM). However, precision therapeutic and diagnostic markers for GSCs have not been fully established. Here, using bioinformatics and experimental analysis, we identified P4HB, a protein disulfide isomerase, as a serum marker that maintains stemness in GSCs through the Wnt/β-catenin signaling pathway. Transcriptional silencing of P4HB induces apoptosis and diminishes stem cell-like characteristics in GSCs. Treatments with the chemical CCF624 or the FDA-approved securinine significantly prolonged the survival in patient-derived xenograft mouse models, underscoring P4HB's potential as a therapeutic target and presenting an expedited path to clinical application through drug repurposing. Additionally, elevated P4HB levels in patient serum were found to correlate with disease progression, underscoring its utility as a biomarker and its promise for precision medicine.

2024-10-11 | GSE271707 | GEO

FIBP maintains colorectal cancer cells stemness via demethylation of stemness genes

Project description:FIBP maintains colorectal cancer cells stemness via demethylation of stemness genes

| PRJNA412214 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the gene expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC). Find potential secretory protein to serve as diagnostic marker for liver cancer.

2019-04-02 | GSE117361 | GEO

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the circular RNA expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC).Find potential circular RNA to serve as diagnostic marker for liver cancer.

2020-10-09 | GSE159220 | GEO

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA668068 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA481878 | ENA

Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs

Project description:Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs

| PRJNA524343 | ENA

Diagnostic marker for lung cancer through microarray analysis

2011-06-14 | GSE29927 | GEO

Diagnostic marker for lung cancer through microarray analysis

Project description:Dr. Kate Olson's Lab is interested to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. In hopes that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. We have already analyzed 4 cell lines and we saw gene expression variability related to how metastatic the cell lines were. This has been written and submitted for publication. We would like to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. We hope that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. The samples were dissected by a pathologist prior to extraction to maximize the amount of normal tissue included in the tumor samples. RNA samples from non tumor and tumor lung cancer patients were received by Core E. The RNA was amplified, labeled, and hybridized to the GLYCOv3 microarrays.

2011-06-14 | E-GEOD-29927 | biostudies-arrayexpress

Repression of ARNT2 Maintains Stemness and Limits Differentiation of Glioblastoma Cells

Project description:Repression of ARNT2 Maintains Stemness and Limits Differentiation of Glioblastoma Cells

| PRJNA991462 | ENA